GGrantIndex
← Leaderboards

Meso Scale Diagnostics, Llc

Gaithersburg, MD

Compare ↔
$35,707,764
Total funding
26
Grants

Funding over time

peak $5.1M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$35,707,764 · 26

By mechanism

N01$5,753,709 · 1
UH3$4,665,347 · 2
UC1$4,309,573 · 1
U01$4,302,224 · 2
U24$4,209,407 · 2
R01$3,513,975 · 2

Investigators at Meso Scale Diagnostics, Llc

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1David Aaron Routenberg$2,815,7251 gr

All-Time

Most funded here, all years

1George B Sigal$3,077,6401 gr2David Aaron Routenberg$2,815,7251 gr3John H Kenten$1,630,2052 gr4Anu Mathew$813,9643 gr5Jeff D Debad$245,5111 gr6Martin Stengelin$199,7661 gr7Ilia Davydov$100,0001 gr

Largest grants

Multiplexed POC Diagnostic System for Bio-Threat Agents$4,309,573
UC1 · FY2005 · AI
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$1,958,323
N01 · FY2017 · AI
COVID 19 Supplemental work: HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$1,499,726
N01 · FY2020 · AI
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$1,452,037
N01 · FY2018 · AI
SBIR PHASE II: AUTOMATED MULTI-ARRAY PLATFORM FOR CANCER BIOMARKERS$998,408
N44 · FY2009 · CA
Surface Signatures of Neuronal and Glial Extracellular Vesicles$895,446
UH3 · FY2022 · MH
Surface Signatures of Neuronal and Glial Extracellular Vesicles$895,420
UH3 · FY2021 · MH
Surface Signatures of Neuronal and Glial Extracellular Vesicles$893,837
UH3 · FY2020 · MH
Blood test to aid treatment decisions for perinatal asphyxiation$870,483
U01 · FY2023 · NS
Blood test to aid treatment decisions for perinatal asphyxiation$866,000
U01 · FY2020 · NS
Enabling isolation and characterization of single extracellular vesicles and their molecular contents using multi-marker surface signatures$855,054
UH3 · FY2021 · TR
A Flexible High-Throughput Immunological Assay to Support Next-Generation Influenza Vaccine Studies$842,062
UH2 · FY2023 · AI
A Flexible High-Throughput Immunological Assay to Support Next-Generation Influenza Vaccine Studies$837,128
UH2 · FY2024 · AI
Enabling isolation and characterization of single extracellular vesicles and their molecular contents using multi-marker surface signatures$836,182
UH3 · FY2022 · TR
Blood Test to Aid Treatment Decisions for Perinatal Asphyxiation$828,886
U01 · FY2021 · NS
TAS::75 0849::TAS ANTIBODY ARRAY FOR DETECTION OF LUNG CANCER$799,999
N44 · FY2010 · CA
Opening a window into immune system signaling at the fg/ml level$758,544
U24 · FY2018 · AI
TAS::75 0849::TAS PHARMACODYNAMIC ASSAYS FOR CANCER THERAPEUTICS$756,981
N44 · FY2010 · CA
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$730,677
N01 · FY2019 · AI
Multimarker surface signatures of human islet derived extracellular vesicles$718,189
R01 · FY2022 · DK